Individuals with obesity exhibit markedly reduced immunological tolerance, leading to excessive production of inflammatory mediators such as IL-6, TNF-α, IL-1β, and IFN-γ, alongside a significant decrease in anti-inflammatory cytokines like IL-4 and IL-10. Here, IL1B is linked to obesity disorder.